vTv Therapeutics Announces Publication in Diabetes Care of Results from SimpliciT-1 Study of TTP399 in Patients with Type 1 Diabetes

Ads

You May Also Like

Celyad Receives the First US Patent Covering a Method of Producing Allogeneic TCR-Deficient CAR T-Cells

MONT-SAINT-GUIBERT, Belgium, March 02, 2016 (GLOBE NEWSWIRE) -- Celyad (Euronext Brussels:CYAD) (Paris:CYAD) (NASDAQ:CYAD), a ...

ADMA Biologics Reports Successful Close-Out of its April 2018 FDA Compliance Inspection

FDA Establishment Inspection Report (“EIR”) ReceivedRAMSEY, N.J. and BOCA RATON, Fla., July 26, 2018 ...

Aduro Biotech Bolsters Intellectual Property Position in STING Field with Two New Patents

BERKELEY, Calif., Aug. 09, 2017 (GLOBE NEWSWIRE) -- Aduro Biotech, Inc. (Nasdaq:ADRO), a biopharmaceutical ...